InvestSMART

Genetic Signatures Limited (ASX: GSS) - Announcements

- Current share price for GSS : $0.059

ASX company news and announcements for Genetic Signatures Limited (GSS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Genetic Signatures Limited (GSS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Genetic Signatures Limited (GSS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Genetic Signatures Limited (GSS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$13 Quarterly update and Appendix 4C 27 Jul 2022 10:16AM $1.100 $0.059 fallen by 94.64%
$13 Clinical trial recruitment completed for US enteric kit 26 Jul 2022 11:44AM $1.130 $0.059 fallen by 94.78%
$13 Notification of cessation of securities - GSS 13 May 2022 12:32PM $1.280 $0.059 fallen by 95.39%
$13 Application for quotation of securities - GSS 13 May 2022 12:31PM $1.280 $0.059 fallen by 95.39%
$13 Initial Director's Interest Notice 13 May 2022 10:50AM $1.260 $0.059 fallen by 95.32%
$13 Director Appointment 13 May 2022 9:49AM $1.210 $0.059 fallen by 95.12%
$13 Notification of cessation of securities - GSS 3 May 2022 3:45PM $1.255 $0.059 fallen by 95.30%
$13 Application for quotation of securities - GSS 3 May 2022 3:44PM $1.255 $0.059 fallen by 95.30%
$13 Investor presentation 27 Apr 2022 8:11AM $1.355 $0.059 fallen by 95.65%
$13 Quarterly update and Appendix 4C 26 Apr 2022 9:18AM $1.340 $0.059 fallen by 95.60%
$13 Application for quotation of securities - GSS 12 Apr 2022 3:36PM $1.300 $0.059 fallen by 95.46%
$13 Public Health Wales Awards Enteric Testing Contract to GSS 30 Mar 2022 8:56AM $1.170 $0.059 fallen by 94.96%
$13 S&P DJI Announces March 2022 Quarterly Rebalance 4 Mar 2022 5:02PM $1.200 $0.059 fallen by 95.08%
$13 Company presentation 18 Feb 2022 11:35AM $1.360 $0.059 fallen by 95.66%
$13 Half Yearly Report and Accounts 18 Feb 2022 8:57AM $1.340 $0.059 fallen by 95.60%
$13 Investor webinar presentation 17 Feb 2022 9:26AM $1.340 $0.059 fallen by 95.60%
$13 Application for quotation of securities - GSS 1 Feb 2022 4:27PM $1.380 $0.059 fallen by 95.72%
$13 Investor presentation 28 Jan 2022 11:08AM $1.300 $0.059 fallen by 95.46%
$13 Quarterly update and Appendix 4C 21 Jan 2022 9:27AM $1.560 $0.059 fallen by 96.22%
$13 Application for quotation of securities - GSS 20 Jan 2022 3:26PM $1.540 $0.059 fallen by 96.17%
$13 3base SARS-CoV-2 kit registered by TGA for saliva samples 10 Jan 2022 10:32AM $1.660 $0.059 fallen by 96.45%
$13 Investor update 21 Dec 2021 12:26PM $1.290 $0.059 fallen by 95.43%
$13 Change of Director's Interest Notice 22 Nov 2021 3:47PM $1.300 $0.059 fallen by 95.46%
$13 Notification regarding unquoted securities - GSS 22 Nov 2021 3:45PM $1.300 $0.059 fallen by 95.46%
$13 Notification of cessation of securities - GSS 22 Nov 2021 3:40PM $1.300 $0.059 fallen by 95.46%

201 - 225 of 504 results

Page 9 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.